AREV CEO Michael Withrow Purchases 900,000 Shares of Company

VANCOUVER, British Columbia, June 11, 2021 (Globe NEWSWIRE) — AREV NANOTEC Brand names INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce that its Chief Govt Officer, Michael Withrow, has ordered a overall of 900,000 shares, such as non-public placement purchases and the working out of warrants.

Mr. Withrow acquired, through his wholly owned entity, Chiron Capital Inc., the shares by exercising 500,000 warrants at a price tag of $.08 for every warrant and obtaining 400,000 models in the Company’s non-public placement at a selling price of $.25 for every unit, the forex in CAD. Each unit consist of 1 typical share and 1 typical share invest in warrant (each, a “Warrant”), every single complete Warrant entitles the holder thereof to invest in a single supplemental common share (the “Warrant Shares”) of the Company at a cost of $.28 per share, at any time on or in advance of 5:00 p.m. (Vancouver time) on the date that is 24 months from the date of issuance of the Warrants besides that, if around a interval of 10 consecutive buying and selling days between the day that is 4 months and a working day from the date of issuance of the Warrants and the date that the Warrants would if not expire, the closing price of the Company’s widespread shares on the Canadian Securities Exchange (or these kinds of other stock exchange the place the majority of the investing volume for the Company’s widespread shares takes place) is at or exceeds $.75, then the Firm might, at its selection, offer penned discover to the warrant holders to training their Warrants within just 30 times of the day of the discover, failing which the Warrants will expire (the “Exercise Period”).

This order provides Mr. Withrow’s total holdings to 12,103,000, symbolizing 47.59% of the Company’s equity.

Mr. Withrow commented: “When I study our core competencies and eyesight, along with the people today doing work with the Company, I see a large prospect in the a number of marketplaces that we operate in. The world-wide daily life science market place size was valued USD 49.82 billion in 2019 and expected to surpass USD 95.68 billion by 2027 with a CAGR of 8.5% from 2020 to 2027, according to Precedence Research. We have engaged attained researchers and have outstanding systems to develop revolutionary answers in just this field, leaving numerous many years of forward growth nonetheless on the desk.” He continued: “When I feel of the therapeutic innovations in our pipeline, there are excellent prospective customers for fast expansion, and that is why I am investing so greatly in AREV.”

AREV proceeds to make several extracts and sophisticated compounds from targeted normal sources to be characterised by collaborative companions and our network of gurus on the AREV Scientific Advisory Board and all those performing for the Business at the junction of science and community wellbeing. These relationships allow the Business to structure and produce progressive merchandise in a shorter time frame than present-day market criteria.

The enterprise has issued 100,000 inventory alternatives to Directors, Officers and Consultants of the Firm at a cost of $.185 for a time period of 5 decades from the issued day. These alternatives will vest promptly.

For further facts, contact Mike Withrow, [email protected] 778-929-6536. For more data visit www.arevlifesciences.com

On behalf of the Board,

Mike Withrow
CEO & Director

About AREV NanoTec Inc.
AREV NanoTec Models Inc. (“AREV”) produces and sells practical components generated by using its proprietary extraction programs. These high quality components and products are qualified for the pure wellness, professional medical, useful meals, nutraceutical, sport nutrition markets for the two the human and pet marketplace. AREV’s design is to toll procedure extraction of qualified crucial and purposeful oils and license its formulations to Licensed Producers in Canada.  The company makes use of toll processors in international nations to encapsulate and deal its formulations that can be offered in standard distribution channels and on-line.

NEITHER THE CANADIAN SECURITIES Exchange NOR ITS Regulations Services Service provider HAVE REVIEWED OR Settle for Accountability FOR THE ADEQUACY OR Precision OF THIS Release.

Forward Looking Information and facts
Neither the Canadian Securities Trade nor its Regulation Products and services Supplier (as that phrase is outlined in procedures of the CSE) accepts duty for the adequacy or accuracy of this release. This information launch may possibly include forward-wanting statements that are subject matter to dangers and uncertainties. All statements inside of, other than statements of historical reality, are to be thought of forward wanting. Even though the Enterprise believes the expectations expressed in these kinds of forward wanting statements are centered on realistic assumptions, these kinds of statements are not ensures of future efficiency and genuine outcomes or developments could differ materially from those people in ahead-searching statements. Factors that could result in true outcomes to vary materially from those in ahead-seeking statements include things like market selling prices, exploitation and exploration successes, and ongoing availability of money and funding, and common financial, current market or company conditions. There can be no assurances that this sort of statements will verify exact and, thus, readers are suggested to count on their individual analysis of these kinds of uncertainties. We do not believe any obligation to update any ahead-looking statements except as expected under the applicable guidelines. This push release has forward-searching statements. The use of any of the words “anticipate”, “continue”, “estimate”, “anticipate”, “may”, “will”, “job”, “really should”, “consider” and identical expressions are supposed to detect forward-on the lookout statements. Despite the fact that the Company believes that the anticipations and assumptions on which the forward-on the lookout statements are centered are acceptable, undue reliance really should not be put on the ahead-hunting statements simply because the Enterprise can give no assurance that they will confirm to be proper. Due to the fact ahead-hunting statements tackle potential situations and ailments, by their incredibly character they require inherent dangers and uncertainties. These statements speak only as of the day of this press launch. Precise final results could differ materially from all those at the moment anticipated owing to a selection of components and risks several danger elements reviewed in the Company’s Management’s Dialogue and Investigation less than the Company’s profile on www.sedar.com.